N Jessen
Overview
Explore the profile of N Jessen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
377
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mose M, Brodersen K, Rittig N, Schmidt J, Jessen N, Mikkelsen U, et al.
Am J Clin Nutr
. 2021 Jun;
114(3):1159-1172.
PMID: 34081111
Background: β-lactoglobulin (BLG) stimulates muscle protein synthesis and β-hydroxybutyrate (BHB) inhibits muscle breakdown. Whether combining the 2 can additively attenuate disease-induced muscle loss is unknown. Objective: Based on previous observations...
2.
Svart M, Rittig N, Pedersen S, Jessen N, Moller N
Diabet Med
. 2020 Aug;
38(2):e14385.
PMID: 32794582
Aims: To test whether oral administration of D/L-3-hydroxybutyrate as a sodium salt inhibits lipolysis and intracellular lipid signalling, in particular, hormone-sensitive lipase, and whether D/L-3-hydroxybutyrate alters endogenous glucose production. Methods:...
3.
Brock C, Jessen N, Brock B, Jakobsen P, Hansen T, Rantanen J, et al.
Diabet Med
. 2017 Jul;
34(10):1428-1434.
PMID: 28703868
Aims: To compare a novel index of parasympathetic tone, cardiac vagal tone, with established autonomic variables and to test the hypotheses that (1) cardiac vagal tone would be associated with...
4.
Sundelin E, Gormsen L, Jensen J, Vendelbo M, Jakobsen S, Munk O, et al.
Clin Pharmacol Ther
. 2017 Apr;
102(5):841-848.
PMID: 28380657
Metformin has been used successfully to treat type 2 diabetes for decades. However, the efficacy of the drug varies considerably from patient to patient and this may in part be...
5.
Gronbaek H, Kreutzfeldt M, Kazankov K, Jessen N, Sandahl T, Hamilton-Dutoit S, et al.
Aliment Pharmacol Ther
. 2016 Sep;
44(10):1062-1070.
PMID: 27679428
Background: Autoimmune hepatitis (AIH) is characterised by liver inflammation with reversibility upon anti-inflammatory treatment. Soluble (s)CD163, a specific macrophage activation marker, is associated with inflammation in other liver diseases, but...
6.
Rittig N, Bach E, Thomsen H, Johannsen M, Jorgensen J, Richelsen B, et al.
Clin Nutr
. 2016 Feb;
35(3):771.
PMID: 26887700
No abstract available.
7.
Rittig N, Bach E, Thomsen H, Johannsen M, Jorgensen J, Richelsen B, et al.
Clin Nutr
. 2015 Apr;
35(2):322-330.
PMID: 25896101
Background & Aims: Inflammation is catabolic and causes muscle loss. It is unknown if amino acid supplementation reverses these effects during the acute phase of inflammation. The aim was to...
8.
Sondergaard E, Gormsen L, Christensen M, Pedersen S, Christiansen P, Nielsen S, et al.
Diabet Med
. 2014 Sep;
32(2):e4-8.
PMID: 25252000
Background: Recruitment of brown adipose tissue is a promising strategy to treat obesity and Type 2 diabetes, but the physiological effects of a large amount of metabolically active brown adipose...
9.
Dudele A, Lund S, Jessen N, Wegener G, Winther G, Elnif J, et al.
J Dev Orig Health Dis
. 2014 Aug;
3(5):364-74.
PMID: 25102266
Dietary protein restriction in pregnant females reduces offspring birth weight and increases the risk of developing obesity, type 2 diabetes and cardiovascular disease. Despite these grave consequences, few studies have...
10.
Vendelbo M, Moller A, Treebak J, Gormsen L, Goodyear L, Wojtaszewski J, et al.
J Appl Physiol (1985)
. 2014 May;
117(3):289-96.
PMID: 24876356
Background: phosphorylation of AS160 and TBC1D1 plays an important role for GLUT4 mobilization to the cell surface. The phosphorylation of AS160 and TBC1D1 in humans in response to acute exercise...